This series was organised by E4H, in partnership with the Academic Health Science Network, London Clinical Network, voluntary sector and NHS England. Supported by Bayer, Daiichi-Sankyo, and Pfizer Limited on behalf of the BMS-Pfizer Alliance

PRESENTATIONS

All delegates who attended these meetings have been sent a password to access the following presentations.

Preventing AF related strokes: A call to action
Professor Tony Rudd

National AHSN Programme
Faye Edwards

Pan-London Approach
Data - Gemma Gerzon
Detect - Sotiris Antoniou
Protect - Helen Williams
Perfect - Helen Cutting

Anticoagulation - Myth Buster
Frances Akor

AF in Primary Care
Diviash Thakrar

Prevention of AF related stroke: Primary Care Challenge
Dr Matt Kearney: GP and National Clinical Director for CVD Prevention, NHS England and Public Health England.

QAF Data - Where are we now?
Helen Williams, FFRPS, FRPharmS, Consultant Pharmacist for Cardiovascular Disease, South London, UK

The National AF Overview
Dr Matt Kearney: GP and National Clinical Director for CVD Prevention, NHS England and Public Health England.

You can watch the video here:

AF Related Stroke - Impact in the SW:

Martin James, Consultant Stroke Physician at Royal Devon & Exeter Hospital; Associate Professor at University of Exeter
You can watch the video here:

NOACs & VKAs Therapy Update
Helen Williams, FFRPS, FRPharmS, Consultant Pharmacist for Cardiovascular Disease, South London, UK
You can watch the video here:

Best Practice Along the AF Pathway
Caroline Smith, Consultant Nurse - Stroke

AF Business Tool
Andi Orlowski: Head of Business Intelligence at Imperial College Health Partners and Senior Population Health Analytics Advisor to NHS England

The National AF Overview
Dr Matt Kearney: GP and National Clinical Director for CVD Prevention, NHS England and Public Health England

AF Regional Perspective
Professor Julia Newton: Medical Director of the AHSN

AF Therapy Options
Helen Williams: Consultant Pharmacist, Cardiovascular Disease Health Innovation, AHSN for South London

State of the Art: Streamlining simple decision making for stroke prevention in Atrial fibrillation
Gregory Y H Lip, Institute of Cardiovascular Sciences, University of Birmingham

The National AF Overview
Dr Matt Kearney: GP and National Clinical Director for CVD Prevention, NHS England and Public Health England

NOACs & VKAs Therapy Update
Sotiris Antoniou, Consultant Pharmacist for Cardiovascular Medicine

The Impact in the Midlands
Dr Indira Natarajan: Consultant Stroke Physician, Clinical Director Neurosciences

PARTNER ORGANISATIONS

AF Association Plain 300 150
auk-logo-full-colour 2
BHF_Logo_Lockup Vertical_BHF_Red_RGB@4x
nhs england
ahsn network

SUPPORTING ORGANISATIONS

These meetings were supported by Bayer, Daiichi-Sankyo, and Pfizer Limited on behalf of the BMS-Pfizer Alliance; these companies had no input to the agenda or speakers, but did exhibit at the meeting. The delegate list was available for those supporting the event, upon request.

Corp-Logo_BG_Bayer-Cross-Logotype_Basic_on-screen_RGB
BMS Pfizer logo small 2
DaiichiLogo 150